Laporan Kasus: Kajian Pengobatan CKD Stage 5 dengan Hiperkalemia

Authors

  • Novianty Indjar Gama Program Studi Farmasi, Fakultas Farmasi, Universitas Mulawarman, Samarinda, Indonesia Author
  • Ferdian George Sarung Allo Program Studi Pendidikan Profesi Apoteker, Fakultas Farmasi, Universitas Mulawarman, Samarinda, Kalimantan Timur, Indonesia Author
  • Fahriani Istiqomah Program Studi Farmasi, Fakultas Farmasi, Universitas Mulawarman, Samarinda, Indonesia Author
  • Angga Cipta Narsa Program Studi Farmasi, Fakultas Farmasi, Universitas Mulawarman, Samarinda, Indonesia Author

Keywords:

Gagal Ginjal Kronis, Stage V, Hiperkalemia

Abstract

Gagal Ginjal Kronis adalah kondisi ketidaknormalan penurunan fungsi ginjal. Laporan Kasus ini berfokus pada kondisi pasien yang mengalami gagal ginjal kronis dengan kondisi hiperkalemia. Pasien mengalami hipertensi dengan tekanan darah 180/ 90 mmHg, saturasi oksigen 92%. Pasien mengeluhkan lemas, nyeri ulu hati, mual, tidak mau makan, kulit gatal dan bengkak pada kedua kaki.  Hasil laboratorium darah diketahui nilai Leukosit yaitu 6,2×103/µl, Ureum 255 mg/dL, Kreatinin 7,2 mg/dl , Natrium 138 mmol/L , Kalium 7,0  mmol/L, serta Hemoglobin 6,3 g/dl dan diagnosa adalah CKD stage V.

References

Romagnani, P. et al., 2017. Chronic kidney disease. Nat. Rev. Dis. Prim. 3.

Nowak-Tim, J. et al., 2021. Chronic Kidney Disease. Pol. Merkur. Lekarski 49, 64–66.

Bikbov, B. et al., 2020. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 395, 709–733.

Hill, N. R. et al., 2016. Global Prevalence of Chronic Kidney Disease-A Systematic Review and Meta-Analysis. doi:10.1371/journal.pone.0158765.

Health Research and Development Agency. 2013. Basic Health Research. Natl. Rep. 1–384.

Vaidya, S. R. & Aeddula, N. R., 2021. Chronic Renal Failure. Sci. Basis Urol. Second Ed. 257–264. doi:10.29309/tpmj/2009.16.04.2736.

Chen, T. K., Knicely, D. H. & Grams, M. E. 2019. Chronic Kidney Disease Diagnosis and Management: A Review HHS Public Access. JAMA 322, 1294–1304.

Chronic Kidney Disease. Harrison’s Principles of Internal Medicine, 20e, Access Medicine McGraw Hill Medical. https://accessmedicine.mhmedical.com/content.aspx?bookid=2129&sectionid=186950702.

Shih, H. M., Wu, C. J. & Lin, S. L., 2018. Physiology and pathophysiology of renal erythropoietin-producing cells. J. Formos. Med. Assoc. 117, 955–963.

Helal, I., Fick-Brosnahan, G. M., Reed-Gitomer, B. & Schrier, R. W., 2012. Glomerular hyperfiltration: Definitions, mechanisms and clinical implications. Nat. Rev. Nephrol. 8, 293–300.

Peacock, W. F. et al., 2018. Real World Evidence for Treatment of Hyperkalemia in the Emergency Department (REVEAL–ED): A Multicenter, Prospective, Observational Study. J. Emerg. Med. 55, 741–750.

Palmer, B. F. et al. 2021. Clinical Management of Hyperkalemia. Mayo Clin. Proc. 96, 744–762.

NKF., 2016. Best Practices in Managing Hyperkalemia in Chronic Kidney Disease. 1–7.

Pugh, D., Gallacher, P. J. & Dhaun, N., 2019. Management of Hypertension in Chronic Kidney Disease. Drugs 79, 365–379.

Cheung, A. K. et al., 2021. KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int. 99, S1–S87.

Bobkova, I., Chebotareva, N., Kozlovskaya, L. & Shilov, E. 2016. Edema in Renal Diseases – Current View on Pathogenesis. Nephrol. @ Point Care 2, pocj.5000204.

Osorio, M. S. & Giraldo, G. C. 2017. Gastrointestinal manifestations of chronic kidney disease. Rev. Colomb. Nefrol. 4, 3–12.

Ammirati, A. L. 2020. Chronic Kidney Disease. REV ASSOC MED BRAS 66, 3–9

Downloads

Published

2024-11-14

Issue

Vol. 4 No. SE-1 (2022): Spesial Edition J. Sains Kes.

Section

Case Report

How to Cite

Laporan Kasus: Kajian Pengobatan CKD Stage 5 dengan Hiperkalemia. (2024). Jurnal Sains Dan Kesehatan, 4(SE-1), 13-16. https://jsk.ff.unmul.ac.id/index.php/JSK/article/view/503

Most read articles by the same author(s)